Review on Pharmacovigilance

Shraddha Anil Naik

doi:10.5958/2231-5691.2020.00024.6

Asian Journal of Pharmaceutical Research

ISSN

2231-5691 (Online)
2231-5683 (Print)

Submit Article

Review on Pharmacovigilance

Author(s): Shraddha Anil Naik

Email(s): nshraddha211@gmail.com

DOI: 10.5958/2231-5691.2020.00024.6

Address: Miss. Shraddha Anil Naik
M.Pharmacy, Appasaheb Birnale College of Pharmacy, Maharashtra, Sangli 416416.
*Corresponding Author

Published In: Volume - 10, Issue - 2, Year - 2020

View HTML

View PDF

ABSTRACT:
Pharmacovigilance definition given by WHO, it is “The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. The number of Adverse Drug Reactions (ADRs) reported, have also resulted in an increase in the volume of data handled. It is a challenge to standardize the act of signal detection and risk management in the context of clinical trials and post-marketing pharmacovigilance. However, with more clinical trials and clinical research activity being conducted in India, and also conducted in phase of clinical trials, Pharmaco epidemiologic study there is an immense need to understand and implement pharmacovigilance. This review describes the various strategies and proposals to build, maintain and implement a robust pharmacovigilance system for various take holders and eventually make it happen in India!

Keywords:

Cite this article:
Shraddha Anil Naik. Review on Pharmacovigilance. Asian J. Pharm. Res. 2020; 10(2):123-128. doi: 10.5958/2231-5691.2020.00024.6

Cite(Electronic):
Shraddha Anil Naik. Review on Pharmacovigilance. Asian J. Pharm. Res. 2020; 10(2):123-128. doi: 10.5958/2231-5691.2020.00024.6 Available on: https://asianjpr.com/AbstractView.aspx?PID=2020-10-2-14

Recomonded Articles:

Banned Drugs: A Review

Author(s): D. Sunitha, K. Hemalatha, M. Sudhakar

DOI: 10.5958/2231-5691.2016.00029.0 Access: Open Access Read More

The Survey of Knowledge about OTC Drugs among Pharmacy Background and Non-Pharmacy Community

Author(s): Pranit P. Gayakar, Rahul S. Adnaik, Amit D. Jadhav, Shrinivas K. Mohite

DOI: Access: Open Access Read More

Nimesulide – A Drug to be Banned completely

Author(s): C. Muralikrishna Goud, Syeda Mariya Ghazanfar

DOI: 10.52711/2231-5691.2021.00025 Access: Open Access Read More

Introduction to Pharmacovigilance and Monitoring

Author(s): Manohar D. Kengar, Kiran K. Patole, Akshay K. Ade, Sumesh M. Kumbhar, Chetan D. Patil, Ashutosh R. Ganjave

DOI: 10.5958/2231-5691.2019.00019.4 Access: Open Access Read More

Iatrogenic Disease

Author(s): Usama Shoukath, Fatima Khatoon, Subayya Mahveen, Mohammed Nayeem Uddin

DOI: 10.5958/2231-5691.2018.00020.5 Access: Open Access Read More

Black Triangle Drugs

Author(s): Anuradha V. P, Betsy Joseph, Jayakrishnan S. S, Ajith B

DOI: 10.5958/2231-5691.2019.00033.9 Access: Open Access Read More

A Review on Diabetes and Its Management

Author(s): Mohd. Yaqub Khan, Poonam Gupta, Bipin Bihari, Vikas Kumar Verma

DOI: Access: Open Access Read More

The Therapeutic Potential of Resveratrol: A Review of Clinical Trials

Author(s): Kanchan R. Pagar, Sarika V. Khandbahale, D. G. Phadtare

DOI: 10.5958/2231-5691.2019.00031.5 Access: Open Access Read More

Assessment of Prevailing Insurance Policies and Regulations in Context of Clinical Research Industry

Author(s): Thakur Abhimanyu, Kondru Sushmita, Kamilya Shruti, Kumar Amit, Goldar Epshita

DOI: 10.5958/2231-5691.2015.00017.9 Access: Open Access Read More

Microneedles: An Advanced approach for Transdermal Delivery of Biologics

Author(s): Popat S. Kumbhar, Tejaswini P. Jadhav, Swapnil S. Chopade, Tejas T. Gavade, Rushikesh C. Sorate, Tejaswini U. Shinde, Pratik P. Maske, John I. Disouza, Arehalli S. Manjappa

DOI: 10.5958/2231-5691.2021.00010.1 Access: Open Access Read More

Review on Pharmacovigilance

Author(s): Shraddha Anil Naik

DOI: 10.5958/2231-5691.2020.00024.6 Access: Open Access Read More

Cancer- A Silent Killer: An Overview

Author(s): Akshay R. Yadav, Shrinivas K. Mohite

DOI: 10.5958/2231-5691.2020.00036.2 Access: Open Access Read More

A Review on Adverse Drug Reaction

Author(s): Manisha Dhondising Rajput, Y. B. Rajput, L. D. Rajput

DOI: 10.5958/2231-5691.2020.00038.6 Access: Open Access Read More

Inhibition of LFA-1/ICAM-1 Interaction: A Therapeutic Strategy for Surmounting Inflammation

Author(s): Monika Gaba, Punam Gaba, Sarbjot Singh, Neelima Dhingra

DOI: 10.5958/2231-5691.2015.00006.4 Access: Open Access Read More

A Laconic Review on Liquid Chromatography Mass Spectrometry (LC-MS) Based Proteomics Technology in Drug Discovery

Author(s): Shivani Sharma, Navdeep Singh, Amar Deep Ankalgi, Arti Rana, Mahendra Singh Ashawat

DOI: 10.52711/2231-5691.2021.00035 Access: Open Access Read More

A Short Review on Study on Different Clinical Trials Performed on Drugs before it Comes into The Market

Author(s): Girish Yogesh Pawar, Rushikesh Rakesh Chaudhari, Tushar Naresh Sonawane, Jayesh Shyam Desale, Suraj K. Ishikar

DOI: 10.52711/2231-5691.2022.00013 Access: Closed Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available
DOI: 10.5958/2231–5691